Overview
The Sponsor-Investigator submits an IND Application to FDA that includes the components listed here.
IND Submission Components
- IND Cover Letter external site (opens in a new window)
- IND Application Template external site (opens in a new window)
- FDA Form 1571 - IND Application external site (opens in a new window) (and FDA Form 1571 Instructions external site (opens in a new window) )
- FDA Form 1572 - Statement of the IND Investigator) external site (opens in a new window) (see sample Box 8 - Protocol Summary Template external site (opens in a new window) )
- FDA Form 3454 - Certification: Financial Interests and Arrangements of Clinical Investigators external site (opens in a new window)
- FDA Form 3455 - Investigator Financial Interest Disclosure external site (opens in a new window)
- FDA Form 3674 - IND Certification of Compliance external site (opens in a new window)
- IND Protocol Template external site (opens in a new window)
IND Forms and Instructions
- IND Forms and Instructions external site (opens in a new window)
- Information for Investigators submitting INDs external site (opens in a new window) (mailing instructions, tips for completing forms, FDA actions upon receipt of the submission)
FDA Guidance
The following FDA documents provide an overview of the IND application process:
- Investigator-Initiated Investigational New Drug (IND) Applications external site (opens in a new window) , especially Regulatory and Administrative Components external site (opens in a new window)
- FAQs about the IND Application external site (opens in a new window)
- Content and Format of IND Applications external site (opens in a new window)
- Exploratory INDs (aka Phase 0) external site (opens in a new window)
For specific situations: